Your browser doesn't support javascript.
loading
Peer2Me - evaluation of a peer supported program for adolescent and young adult (AYA) cancer patients: study protocol of a randomised trial using a comprehensive cohort design.
Brock, Hannah; Dwinger, Sarah; Bergelt, Corinna; Sender, Annekathrin; Geue, Kristina; Mehnert-Theuerkauf, Anja; Richter, Diana.
Afiliação
  • Brock H; Department of Medical Psychology and Medical Sociology, University Medical Center Leipzig, Comprehensive Cancer Center Central Germany (CCCG), Philipp-Rosenthal-Straße 55, 04103, Leipzig, Germany.
  • Dwinger S; Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
  • Bergelt C; Department of Medical Psychology, University Medicine Greifswald, Walther-Rathenau-Straße 48, 17475, Greifswald, Germany.
  • Sender A; Department of Medical Psychology and Medical Sociology, University Medical Center Leipzig, Comprehensive Cancer Center Central Germany (CCCG), Philipp-Rosenthal-Straße 55, 04103, Leipzig, Germany.
  • Geue K; Department of Medical Psychology and Medical Sociology, University Medical Center Leipzig, Comprehensive Cancer Center Central Germany (CCCG), Philipp-Rosenthal-Straße 55, 04103, Leipzig, Germany.
  • Mehnert-Theuerkauf A; Department of Psychosomatic Medicine and Psychotherapy, Medical Faculty, Otto-von-Guericke-University Magdeburg, Leipziger Str. 44, 39120, Magdeburg, Germany.
  • Richter D; Department of Medical Psychology and Medical Sociology, University Medical Center Leipzig, Comprehensive Cancer Center Central Germany (CCCG), Philipp-Rosenthal-Straße 55, 04103, Leipzig, Germany.
BMC Cancer ; 24(1): 788, 2024 Jul 02.
Article em En | MEDLINE | ID: mdl-38956510
ABSTRACT

BACKGROUND:

Developing cancer in young adulthood is a non-normative life event and associated with adverse physical, social and psychological consequences. High psychological distress is common in AYA cancer patients including anxiety, depression or fear of recurrence. At the same time, it is well known that AYA often report unmet needs for support, particularly in terms of informational exchange and emotional support from peers in order to benefit from shared experiences and enhance self-efficacy. Especially in the AYA group, interactions with other same-aged cancer patients may represent an essential resource in terms of coping with the disease, as family members and friends are often overwhelmed and struggling with helplessness. Currently, there is a lack of professional support services using peer support (e.g. psycho-oncological support, aftercare consultations, social legal counselling) or evaluated peer support interventions in Germany. Our aim is to assess the effectiveness of the Peer2Me intervention for AYAs, in which acute patients (mentees) are accompanied by an AYA survivor (mentor) over a period of three months.

METHODS:

A prospective Comprehensive Cohort Design with repeated measures will be used to evaluate the effectiveness of Peer2Me for AYA. A sample of 180 patients in active cancer treatment aged 18 to 39 years will be enrolled and randomized to the intervention or control condition (a single AYA-specific consultation). Following mentor training, mentees and mentors are matched by diagnosis, age, and gender. The primary outcome is self-efficacy; secondary outcomes include measures of anxiety, depression, health literacy, life satisfaction and social support life. Outcomes will be measured at baseline before the intervention (t1), immediately after completion of the three-month intervention (t2) and three months after completion the intervention (t3). For the final analyses, we will use an intention-to-treat approach (ITT) and compare patients in the assigned treatment groups.

DISCUSSION:

Peer2Me might be an important addition to existing professional psychosocial support services for young cancer patients. At the end of the study, a psycho-oncological intervention for young cancer patients undergoing acute treatment should be available, from which both mentors and mentees could benefit. The long-term continuity of Peer2Me should be ensured through collaboration with different partners. TRIAL REGISTRATION The study was retrospectively registered on February 4, 2022 at clinicaltrials.gov (NCT05336318).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Grupo Associado / Apoio Social / Neoplasias Limite: Adolescent / Adult / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Grupo Associado / Apoio Social / Neoplasias Limite: Adolescent / Adult / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha